Enhancing the QUAlity and Transparency Of health Research

EQUATOR resources in German | Portuguese | Spanish

Blog Archives

23/09/2020 STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS guideline 12/10/2016 REporting recommendations for tumour MARKer prognostic studies (REMARK) 28/01/2015 American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants 19/08/2013 The HuGENetâ„¢ HuGE Review Handbook, version 1.0. Guidelines for systematic review and meta-analysis of gene disease association studies 19/08/2013 Publication of population data for forensic purposes 19/08/2013 Publication of population data of linearly inherited DNA markers in the International Journal of Legal Medicine 27/06/2013 Reporting genetic results in research studies: summary and recommendations of an NHLBI working group 26/06/2013 Gene expression-based prognostic signatures in lung cancer: ready for clinical use? 18/06/2013 A community standard for immunogenomic data reporting and analysis: proposal for a STrengthening the REporting of Immunogenomic Studies statement 17/06/2013 STrengthening the REporting of Genetic Association Studies (STREGA): An Extension of the STROBE Statement.

Blog archives

Latest guest blogger

  • Why did we develop TIDieR-Placebo?

    The TIDieR reporting guideline helps authors fully report their interventions, so that they can be used by others. However, TIDieR only explicitly covers active interventions, not placebo controls. The developers of the new TIDieR-Placebo extension explain why it is needed Read More